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journal homepage: www.e-t jo.comEditorialLatest advances in the treatment of corneal diseasesNeurotrophic factors are important factors associated with
epithelialization and stromal wound healing after corneal injury.1
In this issue of the Taiwan Journal of Ophthalmology, Lin et al2 and
Wu et al3 present two autologous preparations from blood, autose-
rum and autologous platelet-rich plasma to treat recalcitrant
LASIK-induced neurotrophic epitheliopathy and refractory corneal
defects respectively. In Lin et al's study, all cases of neurotrophic
epitheliopathy were healed using conventional autologous serum
preparation after LASIK surgery.2 In Wu et al's study, three patients
with neurotrophic ulcer, exposure corneal ulcer and limbal deﬁ-
ciency with corneal ulcer after HSV keratitis respectively were
healed successfully with platelet-rich plasma.3 Both studies indi-
cate the importance of neurotrophic factors in the treatment of
neurotrophic epitheliopathy and stromal defects caused by impair-
ment of trigeminal innervation leading to corneal epithelial break-
down, impairment of healing, and development of corneal
ulceration, melting, and perforation.4 LASIK, diabetes and herpetic
infection, as shown in these two studies, will cause impairment
of trophic nerve ﬁbers in the trigeminal nerve maintaining the
anatomical integrity and function of the ocular surface.1
Autologous serum has been shown to contain essential compo-
nents of tears in comparable concentrations to natural tears.5
Therefore, it has been used as adjunct or alternative treatment of
persistent epithelial defects or neurotrophic ulcer. In fact, autose-
rum eye drops was the ﬁrst hemoderivative product used in the
ophthalmology ﬁeld.6 However, the presence of leukocytes during
the preparation procedure increases the levels of pro-inﬂammatory
cytokines, including IL-6, IL-1b and TNF-a, which cause further
corneal inﬂammation and ulceration.7
Similarly, platelet-rich plasma contains a large pool of proteins
and factors such as PDGF, TGF-b, VEGF, IGF-I, hepatocyte growth
factor (HGF), angiopoietins, platelet factor-4 (PF-4) and thrombo-
spondin, which can also promote corneal epithelialization and stro-
mal wound healing like autologous serum.8 Some preparationshttp://dx.doi.org/10.1016/j.tjo.2015.07.003
2211-5056/Copyright © 2015, The Ophthalmologic Society of Taiwan. Published by Elsevsuch as the new platelet-rich growth factor eye drops are not
diluted as usually happens with autologous serum in particular
medical devices which are EU and FDA accepted at present.5 How-
ever, it is almost impossible to reach an agreement about a deﬁni-
tion of platelet-rich plasma from the variety of preparations
described in the literature.5 There are more than 30 different pro-
tocols and platelet-rich plasma products reported in the literature,
many of which have been commercialized.5 Wu et al's preparation
is relatively simple to make and easy to use clinically.3
An important point to note is that with both blood derivatives,
there is the inevitable increased risk of microbial contamination
leading to corneal infection during treatment. The problems of
contamination and breakdown of components in these blood-
derivative eye drops should be carefully monitored and inspected
during preparation and preservation. A standard protocol for prep-
aration needs to be established in the future.
Also in this issue of the Taiwan Journal of Ophthalmology, Wang
et al9 present two cases of occult Descemet's membrane detach-
ment after phacoemulsiﬁcation surgery mimicking pseudophakic
bullous keratopathy who were scheduled for corneal transplanta-
tion. They warned that occult Descemet's membrane detachment
should be suspected in patients with persistent severe corneal
edema after phacoemulsiﬁcation surgery. Corneal transplantation
should be deferred for 6e12 months until the surgeon can exclude
this possibility. Their case report is interesting and clinically rele-
vant as it has never been reported in the literature. We agree
with the opinions from their case presentation. However, the pos-
sibility of corneal decompensation during long-term follow-up also
needs to be considered.
The ﬁnal article I highlight from this issue of the journal is that of
Sarnicola et al,10 who present their 4-year follow-up results of su-
ture insertion of graft donor in Descemet stripping automated
endothelial keratoplasty. Their unique technique uses a double-
armed 10-0 suture with a straight transchamber needle and half-
circle needle to insert the folded donor lenticule. Only 9 (4.6%) pa-
tients suffered a dislocation of donor tissue; all were successfully
reattached with a second air injection. Only 3 (1.5%) eyes developed
graft failure. Pupillary block was present in 15 (7.7%) eyes. The re-
sults of their method were equivalent to those achieved with cur-
rent insertion devices such as spoon-shaped glide. Their method
provides an alternative should current devices not be available.
Their study also demonstrates that both improvement in surgical
skills and in the devices used in Descemet stripping automated
endothelial keratoplasty are equally important for the outcome of
this surgery.ier Taiwan LLC. All rights reserved.
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